Prevalence of Uterine Malformations in Newly Married Unselected Population

Sponsor
Hacettepe University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04686227
Collaborator
(none)
3,000
1
23
130.4

Study Details

Study Description

Brief Summary

Uterine malformation is occur due to the abnormal development of Mullerian canal during embryogenesis and it is known that it reduces the fertility and live birth rate and also increases the abortion and preterm birth rate. There are different classification methods have been used for defining the uterine malformations. The most common used classification method in the World is American Society of Reproductive Medicine (ASRM)'s system. In addition European Society of Human Reproduction and Embryology (ESHRE) and European Society for Gynaecological Endoscopy (ESGE) developed a new classification system. ASRM Uterine malformation Classification which is used for diagnosis and treatment of uterine malformations in our clinic is subdivided into 7 titles:

  1. Agenesis or Hypoplasia -(a. Vaginal b. Cervical c. Fundal d. Tubal e. Combine)

  2. Unicornuate -(a. Communicating Horn b. Non-Communicating Horn c. No Cavity d. No Horn)

  3. Uterus Didelphus

  4. Bicornuate Uterus-(a. Complete b. Partial)

  5. Uterine Septum- (a. Complete b. Partial)

  6. Arcuate Uterus

  7. Diethylstilboestrol (DES) Related

The diagnosis of some of the uterine malformations have been done by using two dimensional (2D) ultrasonography, hysterosalphingography or surgically (laparoscopy or laparotomy) traditionally. A non-invasive procedure is required for the diagnosis of the uterine malformation, which is evaluating both the uterine contour and endometrial cavity.

In recent years frequently used three dimensional (3D) ultrasound is a non-invasive and quick diagnostic technique, and also it is sensitive as MRI. In hospital based case control studies, the frequency of uterine malformation was generally around 6%, while it was 8% in infertile patients and 12% in patients with abortion. However, there is a lack of prospective studies investigating the prevalence of uterine anomalies, fertility potential and effects on pregnancy outcomes in unselected patient groups in the literature. Therefore, at the high level evidence, there is no evidence that these anomalies affect fertility and pregnancy outcomes and should be corrected. In this study it was aimed to investigate the effects of uterine malformations on fecundability and pregnancy outcomes by evaluating the uterine morphology with 3D ultrasonography and calling for control purposes at the 1st and 2nd years of newly married women between the ages of 18-40.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: 3D Ultrasound

Detailed Description

This study is designed as a prospective observational study. As it was mentioned above, it was aimed to investigate the effects of uterine malformations on fecundability and pregnancy outcomes by evaluating the uterine morphology with 3D ultrasonography and calling for control purposes at the 1st and 2nd years of newly married women between the ages of 18-40. Firstly a template flyer's designed to call the newly married women to our study. To be able to explain the study and call the participants officially, official permission's got from the municipal leading the wedding hall nearby the hospital (In Turkey, wedding halls are managed by the municipality covering their locations. As it's needed, the document can be added.). A scholarship student will explain the study and invite the couples. First and second year After the ultrasound, the participants will be called by phone to ask unprotected sex period; if conceived, outcomes of pregnancy (miscarriage, preterm birth, term birth, malpresentation etc.). Then the data will be worked on SPSS.

Study Design

Study Type:
Observational
Anticipated Enrollment :
3000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prevalence of Uterine Malformations in Newly Married Unselected Population
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Group-1, women with normal uterus

Diagnostic Test: 3D Ultrasound
Newly married women between the ages of 18-40 will be evaluated by 3D ultrasonography about the uterine morphology

Group-2, women with any uterine malformations

Group-2 is going to be sub-grouped according to ASRM and ESHRE classifications

Diagnostic Test: 3D Ultrasound
Newly married women between the ages of 18-40 will be evaluated by 3D ultrasonography about the uterine morphology

Outcome Measures

Primary Outcome Measures

  1. Prevalence of uterine malformations [1 year after inclusion of last participant]

    prevalence of uterine malformations in study population according to ASRM/ESHRE classifications

  2. spontaneous fecundability [1 year after inclusion of last participant]

    1 year fecundability rate in subgroup of malformations and normal uterus

  3. Pregnancy outcomes [During the pregnancy]

    Rate of miscarriage, preterm birth, and malpresentation

  4. Live birth rate [1 year]

    Having a live birth in all subgroups of uterine malformations and normal uterus

  5. comparing of infertility rates [1 year]

    comparing of infertility rates between normal uterus population and every subgroup of uterine malformations

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Husband is under 45 years old
Exclusion Criteria:
  • Azospermia

  • Women with Premature Ovarian Failure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hacettepe UniversityHacettepe University School of Medicine, Department of Ob/Gyn Ankara Turkey 06100

Sponsors and Collaborators

  • Hacettepe University

Investigators

  • Principal Investigator: Sezcan Mumusoglu, Assoc. Prof., Hacettepe University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sezcan Mumusoglu, Associate Professor, Hacettepe University
ClinicalTrials.gov Identifier:
NCT04686227
Other Study ID Numbers:
  • HU3643
First Posted:
Dec 28, 2020
Last Update Posted:
Mar 17, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sezcan Mumusoglu, Associate Professor, Hacettepe University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2022